Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.63 Consensus PT from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […]
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […]
